- Home
- SERA vs SABA Comparison
SERA vs SABA Comparison
Compare SERA & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERA
- SABA
- Stock Information
- Founded
- SERA 2008
- SABA 1988
- Country
- SERA United States
- SABA United States
- Employees
- SERA N/A
- SABA N/A
- Industry
- SERA Precision Instruments
- SABA
- Sector
- SERA Health Care
- SABA
- Exchange
- SERA Nasdaq
- SABA Nasdaq
- Market Cap
- SERA 208.7M
- SABA 246.4M
- IPO Year
- SERA 2021
- SABA N/A
- Fundamental
- Price
- SERA $8.35
- SABA $8.87
- Analyst Decision
- SERA
- SABA
- Analyst Count
- SERA 0
- SABA 0
- Target Price
- SERA N/A
- SABA N/A
- AVG Volume (30 Days)
- SERA 79.3K
- SABA 290.0K
- Earning Date
- SERA 11-06-2024
- SABA 01-01-0001
- Dividend Yield
- SERA N/A
- SABA 12.91%
- EPS Growth
- SERA N/A
- SABA N/A
- EPS
- SERA N/A
- SABA N/A
- Revenue
- SERA $94,000.00
- SABA N/A
- Revenue This Year
- SERA N/A
- SABA N/A
- Revenue Next Year
- SERA $4,471.43
- SABA N/A
- P/E Ratio
- SERA N/A
- SABA N/A
- Revenue Growth
- SERA N/A
- SABA N/A
- 52 Week Low
- SERA $4.90
- SABA $3.64
- 52 Week High
- SERA $12.36
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- SERA 57.84
- SABA 49.76
- Support Level
- SERA $7.91
- SABA $8.73
- Resistance Level
- SERA $8.60
- SABA $9.14
- Average True Range (ATR)
- SERA 0.58
- SABA 0.15
- MACD
- SERA 0.07
- SABA -0.03
- Stochastic Oscillator
- SERA 67.96
- SABA 32.27
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Templeton Global Income Fund is a closed-end fund. It seeks high current income, with a secondary goal of capital appreciation. Under normal market conditions. The Fund invests at least over 80% of its net assets in income-producing securities, including debt securities of the United States and foreign issuers, including emerging markets.